ArticleMolecular cancer therapeutics2016

Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.

Yilin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.